4.22

12.99% -0.63

After Hours: 4.50 0.28 +6.64%

Precigen Inc (PGEN)

Overview News Price History Option Chain Financials Discussions Forecast

Precigen Inc stock is traded at $4.22, with a volume of 5.24M. It is down -12.99% in the last 24 hours and up +5.50% over the past month. Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Previous Close:

$4.85

Open:

$4.79

24h Volume:

5.24M

Relative Volume:

0.79

Market Cap:

$1.26B

Revenue:

$6.23M

Net Income/Loss:

$-95.90M

P/E Ratio:

-10.82

EPS:

-0.39

Net Cash Flow:

$-68.47M

1W Performance:

+4.98%

1M Performance:

+5.50%

6M Performance:

+210.29%

1Y Performance:

+430.42%

1-Day Range:

$4.21

$4.81

1-Week Range:

$3.74

$5.19

52-Week Range:

$0.6513

$5.225

Precigen Inc Stock (PGEN) Company Profile

Name

Precigen Inc

Sector

Healthcare (1130)

Industry

Biotechnology (634)

Phone

301-556-9900

Address

20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD

Employee

Twitter

@precigen

Next Earnings Date

2025-03-19

Latest SEC Filings

PGEN's Discussions on Twitter

Compare PGEN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PGEN Precigen Inc	4.22	1.72B	6.23M	-95.90M	-68.47M	-0.39
VRTX Vertex Pharmaceuticals Inc	421.03	110.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	702.75	76.23B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	460.76	61.08B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	914.59	56.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	203.56	43.00B	447.02M	-1.18B	-906.14M	-6.1812

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-15-25	Upgrade	JP Morgan	Underweight → Neutral
Mar-22-24	Downgrade	JP Morgan	Neutral → Underweight
May-23-23	Initiated	JP Morgan	Neutral
Nov-18-22	Initiated	Cantor Fitzgerald	Overweight
Feb-25-21	Initiated	Stifel	Buy
Feb-22-21	Initiated	Wells Fargo	Overweight
Feb-18-21	Initiated	B. Riley Securities	Buy
May-08-20	Initiated	H.C. Wainwright	Buy

View All

Precigen Inc Stock (PGEN) Latest News

Nov 19, 2025

Is Precigen Inc. stock supported by strong cash flowsMarket Rally & Reliable Breakout Forecasts - newser.com

Nov 19, 2025

Will Precigen Inc. stock benefit from commodity prices2025 Investor Takeaways & Weekly Consistent Profit Watchlists - newser.com

Nov 19, 2025

Precigen (PGEN) Q3 2025 Earnings Call Transcript - AOL.com

Nov 19, 2025

Tools to assess Precigen Inc.’s risk profileQuarterly Market Summary & Daily Price Action Insights - newser.com

Nov 19, 2025

How Precigen Inc. stock performs in interest rate cycles2025 Investor Takeaways & AI Driven Price Forecasts - newser.com

Nov 19, 2025

Will Precigen Inc. stock benefit from AI adoptionJuly 2025 Fed Impact & Daily Market Momentum Tracking - newser.com

Nov 19, 2025

Nov 18, 2025

Is Precigen Inc. stock in correction or buying zoneGap Up & Risk Adjusted Swing Trade Ideas - newser.com

Nov 18, 2025

Using R and stats models for Precigen Inc. forecastingRisk Management & Weekly Top Performers Watchlists - newser.com

Nov 18, 2025

Nov 17, 2025

Intraday pattern recognizer results for Precigen Inc.Quarterly Portfolio Report & Free Community Supported Trade Ideas - newser.com

Nov 17, 2025

Nov 16, 2025

Can technical indicators confirm Precigen Inc.’s reversalJuly 2025 Update & Daily Price Action Insights - newser.com

Nov 16, 2025